José Roberto Leite
São Paulo, 04024-002, Brazil
NCT Number: NCT01157273
Objective: To assess whether the anxiety caused by a task considered anxiogenic, Simulated Public Speaking (SPS) test, would change the responses of healthy individuals regarding physiological and vocal parameters. Method: The sample comprised 30 participants of both genders, 19-42 years old, with no history of psychiatric disorders. The score in the STAI-Trait enabled investigators to assign participants to two groups: LOW ANXIETY (LA) and HIGH ANXIETY (HA). The investigators evaluated physiological parameters (heart rate, skin conductance, temperature in the extremities, electromyogram of the frontal muscle and salivary cortisol) and vocal parameters (vocal self-evaluation, quality of life in voice and vocal symptoms and signs) BEFORE, DURING and AFTER the SPS.
Looking for future studies?
Notify Me18 year–45 year
All sexes
Observational
São Paulo, 04024-002, Brazil
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Federal University of São Paulo
Other
Psychophysiological and Vocal Affections in Subjects Submitted to a Public Speaking Mock Test
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04453475
Anxiety, Anxiety Disorders
Bremen, Germany
View Trial DetailsNCT03668223
Anxiety, Anxiety Disorders
Los Angeles, California, United States
View Trial DetailsNCT06187428
Acute Pain, Anxiety
Svärtinge, Jönköping County, Sweden
View Trial DetailsNCT03702634
Anxiety, Anxiety Disorders
Indianapolis, Indiana, United States
View Trial Details